Blanchard, R., Blanchard, D. C., Griebel, G., and Nutt, D. (Eds.). (2008). Handbook of Anxiety and Fear. San Diego, CA: Elsevier Academic.

Bowers, M. E., and Yehuda, R. (2016). Intergenerational transmission of stress in humans. Neuropsychopharmacology, 41, 232–244.

Farb, D. H., and Ratner, M. H. (2014). Targeting the modulation of neural circuitry for the treatment of anxiety disorders. Pharmacol. Rev., 66, 1002–1032.

Hamm, A. O., and Weike, A. I. (2005). The neuropsychology of fear learning and fear regulation. Int. J. Psychophysiol., 57, 5–14.

LeDoux, J. E. (1996). The Emotional Brain. New York: Simon and Schuster.

Manning, M., Stoev, S., Chini, B., Durroux, T., Mouillac, B., and Guillon, G. (2008). Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: Research tools and potential therapeutic agents. Prog. Brain Res., 170, 473–512.

Martin, E. I., Ressler, K. J., Binder, E., and Nemeroff, C. B. (2010). The neurobiology of anxiety disorders: Brain imaging, genetics, and psychoneuroendocrinology. Clin. Lab. Med., 30, 865–891.

McEwen, B. S. (2010). Stress, sex, and neural adaptation to a changing environment: Mechanisms of neuronal remodeling. Ann. N. Y. Acad. Sci., 1204 (Suppl. E), 38–59.

Nuss, P. (2015). Anxiety disorders and GABA neurotransmission: A disturbance of modulation. Neuropsychiatr. Dis. Treat., 11, 165–175.

Pinna, G., and Rasmusson, A. M. (2014). Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder. Front. Cell. Neurosci., 8, Article 256, 1–11.

Reddy, D. S. (2010). Neurosteroids: Endogenous role in the human brain and therapeutic potentials. Prog. Brain Res., 186, 113–137.

Rotzinger, S., Lovejoy, D. A., and Tan, L. A. (2010). Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides, 31, 736–756.

Wang, J., Korczykowski, M., Rao, H., Fan, Y., Pluta, J., Gur, R. C., et al. (2007). Gender difference in neural response to psychological stress. Soc. Cogn. Affect. Neurosci., 2, 227–239.

Witkin, J. M., Tzavara, E. T., and Nomikos, G. G. (2005). A role for cannabinoid CB₁ receptors in mood and anxiety disorders. Behav. Pharmacol., 16, 315–331.